FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048014123> ?p ?o ?g. }

• W3048014123 abstract "We previously have revealed that 1-trifluoromethoxyphenyl-3-(1- propionylpiperidin-4-yl) urea (TPPU), as a soluble epoxide hydrolase (sEH) inhibitor can reduce infarct volume, protect blood-brain barrier (BBB) and brain against ischemic injury in rats. Here, we investigated the potential mechanisms of TPPU on BBB integrity in both in permanent middle cerebral artery occlusion (pMCAO) rat model and in oxygen-glucose deprivation/reperfusion (OGD/R)-induced human brain microvascular endothelial cells (HBMVECs) model. In pMCAO rat, TPPU administration decreased brain edema and Evans blue content, increased tight junction proteins (TJs) expression of claudin-5, occludin and zonula occludens-1 (ZO-1). In OGD/R model, OGD/R significantly increased permeability and cell apoptosis, downregulated the expression of claudin-5, ZO-1, occludin, and lymphoma (Bcl)-2. Notably, TPPU pretreatment effectively protected the BBB integrity by reducing the permeability, promoting expression of claudin-5, ZO-1, occluding and Bcl-2, mitigating reactive oxygen species (ROS) injury and release of interleukin-1β (IL-1β), IL-6β and tumour necrosis factor-α (TNF-α), downregulating expression of matrix metalloproteinase-9 (MMP-9), MMP-2, bcl-2-associated X protein (Bax), IL-1β, IL-6β, TNF-α. Moreover, OGD/R induced the up-regulation of p-p65, p-IκB and p-p38, which were effectively decreased after TPPU pretreat¬ment in comparison with that of the OGD/R group. Furthermore，pyrrolidinedithiocarbamate (PDTC, a selective inhibitor of NF-κB p65) not only alleviated the OGD/R-induced HBMVECs injury and permeability, but also reduced the expression of TNF-α, IL-6, IL-1β, p-p65 and p-IκB, and the protective effect of PDTC was equivalent to that of TPPU. These results indicate that TPPU protects BBB integrity against ischemic injury by multiple protective mechanisms, at least in part, by reducing ROS, inflammation, apoptosis, and suppressing the nuclear factor-κB (NF-κB) and p38 signaling pathways." @default.
• W3048014123 created "2020-08-13" @default.
• W3048014123 creator A5004072430 @default.
• W3048014123 creator A5008346473 @default.
• W3048014123 creator A5008949503 @default.
• W3048014123 creator A5026321844 @default.
• W3048014123 creator A5030968272 @default.
• W3048014123 creator A5059313115 @default.
• W3048014123 creator A5070276429 @default.
• W3048014123 creator A5071574297 @default.
• W3048014123 creator A5084637151 @default.
• W3048014123 creator A5087892686 @default.
• W3048014123 date "2020-08-07" @default.
• W3048014123 modified "2023-10-18" @default.
• W3048014123 title "1-Trifluoromethoxyphenyl-3-(1-Propionylpiperidin-4-yl) Urea Protects the Blood-Brain Barrier Against Ischemic Injury by Upregulating Tight Junction Protein Expression, Mitigating Apoptosis and Inflammation InVivo and In Vitro Model" @default.
• W3048014123 cites W1191486974 @default.
• W3048014123 cites W1965988966 @default.
• W3048014123 cites W1974444929 @default.
• W3048014123 cites W1979309119 @default.
• W3048014123 cites W1988492326 @default.
• W3048014123 cites W2016348267 @default.
• W3048014123 cites W2017589879 @default.
• W3048014123 cites W2027990732 @default.
• W3048014123 cites W2036093656 @default.
• W3048014123 cites W2045654674 @default.
• W3048014123 cites W2049760255 @default.
• W3048014123 cites W2066189463 @default.
• W3048014123 cites W2074305473 @default.
• W3048014123 cites W2089254388 @default.
• W3048014123 cites W2093486401 @default.
• W3048014123 cites W2111972561 @default.
• W3048014123 cites W2147041159 @default.
• W3048014123 cites W2149448669 @default.
• W3048014123 cites W2171165037 @default.
• W3048014123 cites W2174168899 @default.
• W3048014123 cites W2198424971 @default.
• W3048014123 cites W2287574303 @default.
• W3048014123 cites W2346238598 @default.
• W3048014123 cites W2411418406 @default.
• W3048014123 cites W2469801881 @default.
• W3048014123 cites W2511053273 @default.
• W3048014123 cites W2549850175 @default.
• W3048014123 cites W2558246423 @default.
• W3048014123 cites W2565680151 @default.
• W3048014123 cites W2580004950 @default.
• W3048014123 cites W2619713113 @default.
• W3048014123 cites W2622534643 @default.
• W3048014123 cites W2625210425 @default.
• W3048014123 cites W2771763619 @default.
• W3048014123 cites W2790969368 @default.
• W3048014123 cites W2793605215 @default.
• W3048014123 cites W2794604265 @default.
• W3048014123 cites W2887303707 @default.
• W3048014123 cites W2896377179 @default.
• W3048014123 cites W2920402363 @default.
• W3048014123 cites W2934600069 @default.
• W3048014123 cites W2940141697 @default.
• W3048014123 cites W2952700061 @default.
• W3048014123 cites W2959849100 @default.
• W3048014123 cites W3008095487 @default.
• W3048014123 cites W4211073154 @default.
• W3048014123 cites W4255683973 @default.
• W3048014123 doi "https://doi.org/10.3389/fphar.2020.01197" @default.
• W3048014123 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7427473" @default.
• W3048014123 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32848796" @default.
• W3048014123 hasPublicationYear "2020" @default.
• W3048014123 type Work @default.
• W3048014123 sameAs 3048014123 @default.
• W3048014123 citedByCount "17" @default.
• W3048014123 countsByYear W30480141232020 @default.
• W3048014123 countsByYear W30480141232021 @default.
• W3048014123 countsByYear W30480141232022 @default.
• W3048014123 countsByYear W30480141232023 @default.
• W3048014123 crossrefType "journal-article" @default.
• W3048014123 hasAuthorship W3048014123A5004072430 @default.
• W3048014123 hasAuthorship W3048014123A5008346473 @default.
• W3048014123 hasAuthorship W3048014123A5008949503 @default.
• W3048014123 hasAuthorship W3048014123A5026321844 @default.
• W3048014123 hasAuthorship W3048014123A5030968272 @default.
• W3048014123 hasAuthorship W3048014123A5059313115 @default.
• W3048014123 hasAuthorship W3048014123A5070276429 @default.
• W3048014123 hasAuthorship W3048014123A5071574297 @default.
• W3048014123 hasAuthorship W3048014123A5084637151 @default.
• W3048014123 hasAuthorship W3048014123A5087892686 @default.
• W3048014123 hasBestOaLocation W30480141231 @default.
• W3048014123 hasConcept C109523444 @default.
• W3048014123 hasConcept C126322002 @default.
• W3048014123 hasConcept C177779419 @default.
• W3048014123 hasConcept C185592680 @default.
• W3048014123 hasConcept C190283241 @default.
• W3048014123 hasConcept C203014093 @default.
• W3048014123 hasConcept C2775962179 @default.
• W3048014123 hasConcept C2776914184 @default.
• W3048014123 hasConcept C2777649898 @default.
• W3048014123 hasConcept C2778402981 @default.
• W3048014123 hasConcept C502942594 @default.
• W3048014123 hasConcept C529278444 @default.
• W3048014123 hasConcept C55493867 @default.
• W3048014123 hasConcept C71924100 @default.
• W3048014123 hasConcept C98274493 @default.

• next